|Issuer:||SHOCKWAVE MEDICAL, INC. (SWAV)|
|Original Submission Date:|
C/O SHOCKWAVE MEDICAL, INC.
5403 BETSY ROSS DRIVE SANTA CLARA, CA 95054
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|f1||all reported securities were sold at a price of $219.56.|
|f2||the reported total includes an aggregate 65 shares the reporting person has acquired since her form 4 report filed on august 31, 2023 in exempt transactions through automatic payroll deduction and purchase features of the issuers employee stock purchase plan, which is a qualified tax-conditioned plan pursuant to section 423 of the internal revenue code.|